Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma |
University of California San Francisco / Zhenyi An, PhD |
Young Investigator Grants |
2015 |
California |
MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis |
Stanford University / Feng Pan, PhD |
Young Investigator Grants |
2019 |
California |
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine / Alice Bertaina, MD/PhD |
Reach Grants |
2019 |
California |
Investigation of Genetic and Molecular Mechanisms of Second Malignant Neoplasms in a Mouse Model |
University of California San Francisco / Jean Nakamura |
Young Investigator Grants |
2011 |
California |
Identification and Characterization of an Epigenetic Program that Maintains the Self-Renewal of MLL Myeloid Leukemia Stem Cells |
Stanford University / Hon-Kit Wong |
Young Investigator Grants |
2010 |
California |
STING Pathway Activation: The Missing Link between Genomic Instability and Antitumor Immunity in Osteosarcoma |
University of California San Francisco / Elizabeth Young, MD |
Young Investigator Grants |
2021 |
California |
Preclinical Studies of Gli1 Inhibition in Ewing Family Tumors
|
Children’s Hospital Los Angeles / William May |
Innovation Grants |
2008 |
California |
Altered Cerebral Blood Flow after Pediatric Posterior Fossa Brain Tumor Treatment |
Children’s Hospital Los Angeles / Mary Baron Nelson, RN/PhD |
Nurse Researcher Grants |
2016 |
California |
Neural Crest Gene Regulatory Networks Underlying Normal Meningeal Development and Onset of Meningioma |
California Institute of Technology / Ayyappa Raja Desingu Rajan, PhD |
Young Investigator Grants |
2021 |
California |
Modeling Pediatric Leukemia in the Zebrafish to Enable Discovery of New Anti-Leukemic Compounds |
University of California, San Diego / David Traver, MD |
Innovation Grants |
2012 |
California |